Codice QR

Isoalantolactone induces the apoptosis of oxaliplatin-resistant human colorectal cancer cells mediated by ROS generation and activation of JNK and p38 MAPK

Abstract Treating colorectal cancer (CRC) poses challenges due to the lack of specific molecular targets. Although oxaliplatin (Ox) is commonly used to treat CRC, resistance frequently develops, necessitating the discovery of new therapeutics. This study explored the anticancer effects of Isoalantol...

Descrizione completa

Salvato in:
Autori principali: Seung-On Lee, Sang Hoon Joo, Na Yeong Lee, Seung-Sik Cho, Goo Yoon, Ki-Taek Kim, Yung Hyun Choi, Jin Woo Park, Joon-Seok Choi, Jung-Hyun Shim
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Portfolio 2025-04-01
Serie:Scientific Reports
Soggetti:
Isoalantolactone
Apoptosis
Colorectal cancer
Oxaliplatin
Reactive oxygen species
JNK/p38 MAPK
Accesso online:https://doi.org/10.1038/s41598-025-98499-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi